Senomyx Inc Has Bullish Trade, Lagoda Investment Management Bought Stake!

February 15, 2018 - By Michael Collier

 Senomyx Inc Has Bullish Trade, Lagoda Investment Management Bought Stake!

Investors sentiment increased to 1 in 2017 Q3. Its up 0.11, from 0.89 in 2017Q2. It is positive, as 7 investors sold Senomyx, Inc. shares while 12 reduced holdings. 8 funds opened positions while 11 raised stakes. 12.74 million shares or 6.81% less from 13.67 million shares in 2017Q2 were reported.

Hilltop Holdings holds 0% or 10,200 shares in its portfolio. Renaissance Technology Ltd Liability accumulated 325,000 shares. Wharton Business Grp Inc Ltd Limited Liability Company has 0% invested in Senomyx, Inc. (NASDAQ:SNMX). 938,475 were accumulated by Blackrock. Bridgeway Capital Mngmt reported 18,300 shares. Vanguard Grp Incorporated Incorporated has invested 0% in Senomyx, Inc. (NASDAQ:SNMX). Northern Tru Corp invested in 118,620 shares or 0% of the stock. 257,262 are owned by Geode Cap Management Lc. Thompson Davis owns 0% invested in Senomyx, Inc. (NASDAQ:SNMX) for 3,000 shares. Jacobs Levy Equity Mgmt reported 190,856 shares or 0% of all its holdings. Messner Smith Theme Value Investment Mgmt Ltd Ca holds 0% of its portfolio in Senomyx, Inc. (NASDAQ:SNMX) for 1,662 shares. Guggenheim Capital Ltd has invested 0% of its portfolio in Senomyx, Inc. (NASDAQ:SNMX). Davenport Co Limited Liability Com has 0% invested in Senomyx, Inc. (NASDAQ:SNMX) for 89,100 shares. Lagoda Inv Mgmt Limited Partnership has 1.48M shares for 0.32% of their portfolio. State Street, a Massachusetts-based fund reported 22,600 shares.

The New Lagoda Investment Management Holding in Senomyx Inc

Lagoda Investment Management reported SC 13G/A form with the SEC for Senomyx Inc. Access it here: 000090571818000204. As reported by Lagoda Investment Management, the filler owns 4.2% or 2,043,935 shares of the Health Care–company.

Senomyx Inc stake is new for [reportingPerson]. Date of activity: December 31, 2017. This shows Lagoda Investment Management’s positive view for Senomyx Inc. For a institutional investor managing $725.00 million in assets and having 11+ experts this is interesting position.

Senomyx Inc Institutional Sentiment

Filings show 76 investors own Senomyx Inc. The ownership in Q3 2015 is high, at Infinity of the outstanding shares. This is increased by 4312440. 24825597 were owned by these investors. 13 funds opened new Senomyx Inc stakes, 19 increased positions. There were 7 that closed positions and 28 reduced them.

Lagoda Investment Management Lp is an investor bullish on Senomyx Inc, owning 4206491 shares as of Q3 2015 for 5.48% of its portfolio. Independence Capital Asset Partners Llc owns 55670 shares or 0.35% of its portfolio. CT Bourgeon Capital Management Llc have 0.26% of its portfolio for 84495 shares. Further, Burnham Asset Management Corp reported stake worth 0.06% of its portfolio. The X1 Ancora Advisors Llc owns 69000 shares. Senomyx Inc is 0.04% of its portfolio.

Business Profile

Senomyx, Inc. is focused on using taste receptor technologies to discover, develop and commercialize flavor ingredients for the packaged food, beverage and ingredient supply industries. The Company operates through development and commercialization of flavor ingredients segment. It is engaged in the discovery, development and/or commercialization of flavor ingredients through over five programs. The Sweet Taste Program is focused on developing flavor ingredients or discovering natural sweeteners. The Savory Flavor Program is focused at flavor ingredients to be used in product categories, such as ready meals, sauces, soups and snack foods. The Bitter Blocker Program is focused on flavor ingredients used in products that contain bitter tastants. The Cooling Taste Program is focused at flavor ingredients used in products that consist of cooling agents. The salt taste modifier program is focused on reduction of the level of salt contained in packaged food and beverage products.

SEC Form 13G.

Analysts await Senomyx, Inc. (NASDAQ:SNMX) to report earnings on March, 1. They expect $-0.06 EPS, up 25.00 % or $0.02 from last year’s $-0.08 per share. After $-0.05 actual EPS reported by Senomyx, Inc. for the previous quarter, Wall Street now forecasts 20.00 % negative EPS growth.

The stock increased 1.60% or $0.02 during the last trading session, reaching $1.27. About 29,942 shares traded. Senomyx, Inc. (NASDAQ:SNMX) has declined 58.69% since February 15, 2017 and is downtrending. It has underperformed by 75.39% the S&P500.

Senomyx, Inc. discovers, develops, and commercializes flavor ingredients and natural high intensity sweeteners primarily for the packaged food, beverage, and ingredient supply industries. The company has market cap of $60.69 million. It develops and/or commercializes sweet, savory and salt flavor ingredients, bitter blockers and cooling agents. It currently has negative earnings. The firm licenses its flavor ingredients to its collaborators on an exclusive or co-exclusive basis, as well as sells various flavor ingredients directly to flavor companies.

More notable recent Senomyx, Inc. (NASDAQ:SNMX) news were published by: Seekingalpha.com which released: “Senomyx: A Christmas Present For Investors” on November 17, 2017, also Businesswire.com with their article: “Senomyx, Inc. Sends Letter to Shareholders” published on March 29, 2017, Prnewswire.com published: “SENOMYX AND PEPSICO EXTEND SWEET TASTE PROGRAM COLLABORATION FOR THREE …” on September 30, 2016. More interesting news about Senomyx, Inc. (NASDAQ:SNMX) were released by: Prnewswire.com and their article: “Senomyx Expands Cool Program Collaboration with Firmenich” published on November 14, 2017 as well as Prnewswire.com‘s news article titled: “SENOMYX, INC. ANNOUNCES RESIGNATION OF CHIEF FINANCIAL OFFICER AND PROMOTION …” with publication date: June 09, 2017.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: